Editorial: a new era in anti-neutrophil cytoplasmic antibody vasculitis

Affiliations

¹ Department of Nephrology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Carmen, Pierre-Bénite, France.
² Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

Comment

Denis Fouque et al. Nephrol Dial Transplant. 2019.

. 2019 Mar 1;34(3):379-381.

doi: 10.1093/ndt/gfz002.

¹ Department of Nephrology, Centre Hospitalier Lyon Sud, Université Claude Bernard Lyon 1, Carmen, Pierre-Bénite, France.
² Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.

No abstract available

Comment on

Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 1.
Watts RA. Watts RA. Nephrol Dial Transplant. 2019 Mar 1;34(3):381-383. doi: 10.1093/ndt/gfy405. Nephrol Dial Transplant. 2019. PMID: 30668750 No abstract available.
Should proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibody vasculitis be treated differently: part 2.
Cohen Tervaert JW. Cohen Tervaert JW. Nephrol Dial Transplant. 2019 Mar 1;34(3):384-387. doi: 10.1093/ndt/gfy406. Nephrol Dial Transplant. 2019. PMID: 30668794 No abstract available.